STOCK TITAN

Aurora Cannabis Inc SEC Filings

ACB NASDAQ

Welcome to our dedicated page for Aurora Cannabis SEC filings (Ticker: ACB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

This page provides access to U.S. Securities and Exchange Commission (SEC) filings for Aurora Cannabis Inc. (ACB), a Canada-based global medical cannabis company listed on NASDAQ and the Toronto Stock Exchange. As a foreign private issuer, Aurora reports to the SEC primarily through Form 6-K current reports, which supply interim financial and operational information to investors.

Recent Form 6-K filings include condensed consolidated interim financial statements, management’s discussion and analysis for the three and six months ended September 30, 2025, and officer certifications. These documents outline Aurora’s segment results for global medical cannabis, consumer cannabis and plant propagation, along with adjusted gross margins, adjusted EBITDA, adjusted net income, working capital and details on cannabis inventory and biological assets.

Aurora also files 6-Ks that furnish material news releases, such as announcements of quarterly financial results, conference call schedules, facility investments and other corporate developments. Some of these 6-Ks are incorporated by reference into the company’s registration statements on Form F-10 and Form S-8, which support securities offerings and equity compensation plans.

On Stock Titan, each Aurora filing is paired with AI-powered summaries that explain the key points in clear language. Investors can quickly see how changes in medical cannabis revenue, consumer cannabis performance or plant propagation operations affect overall results, without reading every line of the underlying documents. Filings related to interim financial statements, management’s analysis and certifications are highlighted so users can focus on the disclosures that matter most for understanding ACB’s regulatory and financial reporting profile.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.76%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.19%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.81%
Tags
current report
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.93%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.93%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.8%
Tags
current report
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.22%
Tags
current report
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.22%
Tags
current report

FAQ

How many Aurora Cannabis (ACB) SEC filings are available on StockTitan?

StockTitan tracks 23 SEC filings for Aurora Cannabis (ACB), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Aurora Cannabis (ACB)?

The most recent SEC filing for Aurora Cannabis (ACB) was filed on November 5, 2025.

ACB Rankings

ACB Stock Data

195.08M
56.68M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Canada
Edmonton

ACB RSS Feed